By inhibiting the expression of Gab1, insulin-like growth factor 1 accelerates endothelial cells inflammation and atherosclerosis (40), suggesting that upregulation of miR-29a-3p in AOSD patients could facilitate inflammatory response by decreasing Gab1 expression. The gene discussed is GAB1; the disease is adult-onset Still disease.